Carregant...
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study
OBJECTIVE: To assess the long-term safety, tolerability, and efficacy of fremanezumab, a fully humanized monoclonal antibody approved for the preventive treatment of migraine. METHODS: A 52-week, multicenter, randomized, double-blind, parallel-group study evaluated fremanezumab monthly or quarterly...
Guardat en:
| Publicat a: | Neurology |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7682830/ https://ncbi.nlm.nih.gov/pubmed/32913018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010600 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|